Universal coverage with rising healthcare costs; health outcomes research value in decision-making in Latin America. 2011

Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
Institute for Clinical Effectiveness and Health Policy, Dr. Emilio Ravignani 2024 (C1414CPT), Buenos Aires, Argentina. faugustovski@iecs.org.ar

This is a short summary of the two plenary sessions held at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Latin American Conference in Mexico City (Mexico) in September 2011, with 477 registrants and 235 accepted abstract submissions. The first asked how attainable universal coverage is in the face of rising costs of health technologies; and the second considered the value of health outcomes research to decision-makers. This conference provided a scientific forum where researchers, health technology producers and public and private decision-makers shared their experiences and research in the field of health economic evaluations, health technology assessment and patient-reported outcomes/health-related quality of life studies. It was the third biennial regional meeting in Latin America, the next one being in Buenos Aires (Argentina) in 2013.

UI MeSH Term Description Entries
D007843 Latin America The geographic area of Mexico, Central America, continent of South America and the islands of the Caribbean where Spanish or other Romance language is spoken.
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D003661 Decision Support Techniques Mathematical or statistical procedures used as aids in making a decision. They are frequently used in medical decision-making. Decision Analysis,Decision Modeling,Models, Decision Support,Analysis, Decision,Decision Aids,Decision Support Technics,Aid, Decision,Aids, Decision,Analyses, Decision,Decision Aid,Decision Analyses,Decision Support Model,Decision Support Models,Decision Support Technic,Decision Support Technique,Model, Decision Support,Modeling, Decision,Technic, Decision Support,Technics, Decision Support,Technique, Decision Support,Techniques, Decision Support
D004059 Diffusion of Innovation The broad dissemination of new ideas, procedures, techniques, materials, and devices and the degree to which these are accepted and used. Innovation Diffusion,Diffusion, Innovation
D006302 Health Services Research The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. (From Last, Dictionary of Epidemiology, 2d ed) Health Care Research,Medical Care Research,Research, Health Services,Action Research,Health Services Evaluation,Healthcare Research,Research, Medical Care,Evaluation, Health Services,Evaluations, Health Services,Health Services Evaluations,Research, Action,Research, Health Care,Research, Healthcare
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013673 Technology Assessment, Biomedical Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. Assessment, Biomedical Technology,Assessment, Technology,Biomedical Technology Assessment,Technology Assessment,Technology Assessment, Health,Assessment, Health Technology,Assessments, Biomedical Technology,Assessments, Health Technology,Assessments, Technology,Biomedical Technology Assessments,Health Technology Assessment,Health Technology Assessments,Technology Assessments,Technology Assessments, Biomedical,Technology Assessments, Health
D017048 Health Care Costs The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost. Medical Care Costs,Treatment Costs,Costs, Medical Care,Health Costs,Healthcare Costs,Cost, Health,Cost, Health Care,Cost, Healthcare,Cost, Medical Care,Cost, Treatment,Costs, Health,Costs, Health Care,Costs, Healthcare,Costs, Treatment,Health Care Cost,Health Cost,Healthcare Cost,Medical Care Cost,Treatment Cost
D017063 Outcome Assessment, Health Care Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure). Assessment, Outcome,Outcome Assessment,Outcome Assessment (Health Care),Outcomes Research,Assessment, Outcomes,Outcome Measures,Outcome Studies,Outcomes Assessment,Assessment, Outcome (Health Care),Assessments, Outcome,Assessments, Outcome (Health Care),Assessments, Outcomes,Measure, Outcome,Measures, Outcome,Outcome Assessments,Outcome Assessments (Health Care),Outcome Measure,Outcome Study,Outcomes Assessments,Research, Outcomes,Studies, Outcome,Study, Outcome
D017149 Private Sector That distinct portion of the institutional, industrial, or economic structure of a country that is controlled or owned by non-governmental, private interests. Private Enterprise,Enterprise, Private,Enterprises, Private,Private Enterprises,Sector, Private

Related Publications

Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
April 2015, Lancet (London, England),
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
January 2012, Journal of health organization and management,
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
January 2015, Revista latino-americana de enfermagem,
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
March 2015, Lancet (London, England),
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
March 1994, Acta psiquiatrica y psicologica de America latina,
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
February 2018, Archives of medical research,
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
January 2022, Archives of public health = Archives belges de sante publique,
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
January 2019, World journal of surgery,
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
March 2013, Leukemia research,
Federico Augustovski, and Sebastián García Martí, and Andrés Pichon Riviere, and Adolfo Rubinstein
June 2018, Bulletin of the World Health Organization,
Copied contents to your clipboard!